Indevus / Endo Pharmaceuticals Merger Looks Good to Go [View article]
ENDP has a history of using acquisitions to grow, since their business model revolves around improving existing treatments, not developing them from scratch (this means SHORTER patent exclusivity life, etc), so the deal makes sense - should be a good buffer for ENDP, which was facing the risk of 2013 patent loss of its shingles treatment.
-
ENDP has a history of using acquisitions to grow, since their business model revolves around improving existing treatments, not developing them from scratch (this means SHORTER patent exclusivity life, etc), so the deal makes sense - should be a good buffer for ENDP, which was facing the risk of 2013 patent loss of its shingles treatment.
Jan 07 21:20 pm
|Rating:
0
0
All Comments by Dan Jacome »Indevus / Endo Pharmaceuticals Merger Looks Good to Go [View article]